kontan.co.id
banner langganan top
| : WIB | INDIKATOR |
  • LQ45974,33   -17,61   -1.78%
  • EMAS984.000 -0,40%
  • RD.SAHAM -0.20%
  • RD.CAMPURAN 0.04%
  • RD.PENDAPATAN TETAP 0.12%

Russia rolls out first approved COVID-19 drug as infections pass 500,000


Jumat, 12 Juni 2020 / 07:24 WIB
Russia rolls out first approved COVID-19 drug as infections pass 500,000
ILUSTRASI. A medical specialist walks past personal protective equipment (PPE) in the hospital No. 1 named after N.I. Pirogov, which delivers treatment to patients infected with the coronavirus disease (COVID-19), in Moscow, Russia May 23, 2020. Kirill Zykov/Moscow


Sumber: Reuters | Editor: Barratut Taqiyyah Rafie

KONTAN.CO.ID - MOSCOW. Russia on Thursday rolled out a drug approved to treat patients suffering from the novel coronavirus, its state financial backer said, as the number of infections there surpassed half a million.

The first deliveries of the new antiviral drug, registered under the name Avifavir, were made to some hospitals and clinics across the country, Russia's RDIF sovereign wealth fund said in a press release. RDIF has a 50% share in a joint venture with the drug's manufacturer ChemRar that runs the trials.

The health ministry gave its approval for the drug's use under a special accelerated process while clinical trials, held over a shorter period and with fewer people than many other countries, were still underway.

Read also: China warns students about choosing Australia, citing racist incidents

There is currently no vaccine for COVID-19, the disease caused by the new coronavirus, and human trials of several existing antiviral drugs have yet to show efficacy.

RDIF chief Kirill Dmitriev last week told Reuters the plan was for ChemRar to manufacture enough of the drug to treat around 60,000 people a month.

Dmitriev on Thursday said more than 10 countries had made requests for Avifavir supplies.

Read also: Trump plans to sign bill pressuring China over Uighur Muslim crackdown: source

Negotiations were underway to supply the drug to almost all of Russia's regions, with seven of its more than 80 regions receiving Thursday's initial deliveries, Dmitriev added.




TERBARU
Kontan Academy
Financial Modeling & Corporate Valuation Fundamental Supply Chain Planner Development Program (SCPDP)

[X]
×